LabcorpLH

NYSE · USA · Segment 6 of 8 in the Medicine, pharma & life science value chain: Diagnostics

Samples from across the US end up in Labcorp's laboratories, which handle routine clinical testing alongside genomics and specialty assays. A contract research arm works for drug developers.

Diagnostics: Tests, imaging and assays that support clinical decision-making.

Key metrics

Market cap

$26.2B

Price

$339.34

Today

+0.9%

Return YTD

+34.1%

Return 1Y

+21.6%

P/E

26.1

P/S

1.8

P/B

3.0

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Clinical labsDiagnosticsGenomics

In the value chain

Products & services

Clinical laboratory diagnostics
Specialty testing & genomics
Laboratory services

Competitors

Quest Diagnostics
Sonic Healthcare
Exact Sciences

Risks

Reimbursement pressure
Test price declines

Supply chain

Supplies →

UnitedHealthUNH

← Suppliers

Abbott LaboratoriesABT Bio-Rad LaboratoriesBIO Becton DickinsonBDX IlluminaILMN

Full supply chain for LH →

Same segment: Diagnostics

Abbott LaboratoriesABT NateraNTRA IDEXX LaboratoriesIDXX Quest DiagnosticsDGX HologicHOLX Bio-Rad LaboratoriesBIO

Compare LH

LH vs ABT LH vs NTRA LH vs IDXX LH vs DGX LH vs HOLX LH vs BIO

See where Labcorp sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →